Fig. 2From: Efficacy and safety of transcatheter closure in adults with large or small atrial septal defectsEvent-free rate through 6 months after transcatheter ASD closure. Shown are Kaplan–Meier estimates for patients who received a large or small ASD closure device. Adverse events included device embolization, new-onset atrial arrhythmia, and major bleeding graded as Type 2 or greater according to the BARC definitionBack to article page